Skip to main content

Advertisement

Log in

Nephrogenic fibrosing dermopathy in pediatric patients

  • Brief Report
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Nephrogenic fibrosing dermopathy (NFD) is a rare and recently recognized sclerosing skin disorder of unknown etiology. Reported cases have occurred in patients with chronic renal failure, with or without renal replacement therapy. All previous cases have been reported in older adult patients. We describe two pediatric patients who recently developed this condition and review the existing literature for NFD. Our patients included an 8-year-old boy on peritoneal dialysis with no prior renal transplant and a 19-year-old boy on hemodialysis with a history of previous failed renal transplants. We speculate that the recent emergence of this condition and occurrence in patients with chronic renal failure suggest an association with some newer pharmacological agent that has recently come into wide use. Since both our patients also had previously experienced large vessel thrombosis, hypercoagulable states may also be implicated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE (2000) Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356:1000–1001

    Article  CAS  PubMed  Google Scholar 

  2. Mackay-Wiggan JM, Cohen DJ, Hardy MA, Knobler EH, Grossman ME (2003) Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). J Am Acad Dermatol 48:55–60

    Article  PubMed  Google Scholar 

  3. Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE (2001) Nephrogenic fibrosing dermopathy. Am J Dermatopathol 23:383–393

    Article  CAS  PubMed  Google Scholar 

  4. Perazella MA, Ishibe S, Reilly RF (2003) Nephrogenic fibrosing dermopathy: an unusual skin condition associated with kidney disease. Semin Dial 16:276–280

    Article  PubMed  Google Scholar 

  5. Streams BN, Liu V, Liegeois N, Moschella SM (2003) Clinical and pathologic features of nephrogenic fibrosing dermopathy: a report of two cases. J Am Acad Dermatol 48:42–47

    Article  PubMed  Google Scholar 

  6. Swartz RD, Crofford LJ, Phan SH, Ike RW, Su LD (2003) Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure. Am J Med 114:563–572

    Article  PubMed  Google Scholar 

  7. Cowper S, LeBoit PE, Su LD, Grossman ME, Windham G, Gilliss D, et al (2002) Public health dispatch: fibrosing skin condition among recipients with renal disease—United States and Europe 1997–2002. MMWR 51:25–26

    Google Scholar 

  8. McNeill AM, Barr RJ (2002) Scleromyxedema-like fibromucinosis in a patient undergoing hemodialysis. Int J Dermatol 41:364–367

    Article  PubMed  Google Scholar 

  9. Hubbard V, Davenport A, Jarmulowicz M, Rustin M (2003) Scleromyxoedema-like changes in four renal dialysis patients. Br J Dermatol 148:563–568

    CAS  PubMed  Google Scholar 

  10. Mach JR Jr, Korchik WP, Mahowald MW (1988) Dialysis dementia. Clin Geriatr Med 4:853–867

    PubMed  Google Scholar 

  11. Fine A, Zacharias J (2002) Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int 61:2210–2217

    Article  PubMed  Google Scholar 

  12. Plone MA, Petersen JS, Rosenbaum DP, Burke SK (2002) Sevelamer, a phosphate-binding polymer, is a non-absorbed compound. Clin Pharmacokinet 41:517–523

    CAS  PubMed  Google Scholar 

  13. Marco MP, Muray S, Betriu A, Craver L, Belart M, Fernandez E (2002) Treatment with sevelamer decreases bicarbonate levels in hemodialysis patients. Nephron 92:499–500

    Article  PubMed  Google Scholar 

  14. Sprague SM, Lerma E, McCormmick D, Abraham M, Batlle D (2001) Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol. Am J Kidney Dis 38 [Suppl 5]:S51–S56

    Google Scholar 

  15. Cowper SE, Bucala R (2003) Nephrogenic fibrosing dermopathy: suspect identified, motive unclear. Am J Dermatopathol 25:358

    Article  PubMed  Google Scholar 

  16. Baron PW, Cantos K, Hillebrand DJ, Hu KQ, Ojogho ON, Nehlsen-Cannarella S, Concepcion W (2003) Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis. Am J Dermatopathol 25:204–209

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Dr. Shawn Cowper for useful discussions regarding our patients. This work was presented in abstract form at the 40th annual meeting of the American Society of Dermatopathology in October 2003.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vikas R. Dharnidharka.

Additional information

Sima M. Jain and Stanton Wesson contributed equally to this report

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jain, S.M., Wesson, S., Hassanein, A. et al. Nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol 19, 467–470 (2004). https://doi.org/10.1007/s00467-003-1380-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-003-1380-1

Keywords

Navigation